$AVNR News 4 stocks to watch 3:47 p.m. Sept. 18, 2014 -

New Post Public Reply Private Reply Replies (0) Message Board

Sep 22, 2014 at 12:28 PM

$AVNR News

4 stocks to watch 3:47 p.m. Sept. 18, 2014 - The Trading Deck
5 companies that will benefit from ALS awareness 7:58 a.m. Aug. 22, 2014 - Jennifer Booton
U.S. stock futures cut rise after retail sales 8:53 a.m. Aug. 13, 2013 - Barbara Kollmeyer
Cree, Flowers Foods in focus Tuesday 8:42 a.m. Aug. 13, 2013 - Wallace Witkowski
Yum Brands shares drop on sour China sales 5:23 p.m. Aug. 12, 2013 - Wallace Witkowski
Avanir to promote Merck's diabetes drug Januvia 4:48 p.m. Aug. 12, 2013 - MarketWatch.com
Avanir shares rise after hours on license deal 6:29 p.m. July 2, 2013 - Wallace Witkowski
Avanir, OptiNose enter N. America licensing deal 5:27 p.m. July 2, 2013 - MarketWatch.com
7 gut checks before the stock market's opening bell 6:43 a.m. April 29, 2013 - Shawn Langlois
Avanir Pharmaceuticals shares down 3% 10:37 a.m. Nov. 17, 2010 - Nick Godt
Monday’s biggest gaining and declining stocks 5:25 p.m. Nov. 1, 2010 - Laura Mandaro
Avanir and Allergan lead drug stocks 1:55 p.m. Nov. 1, 2010 - Val Brickates Kennedy
Avanir leads drug stocks north 10:06 a.m. Nov. 1, 2010 - Val Brickates Kennedy
Rexahn, Avanir gain; Sequenom falls 1:32 p.m. April 7, 2010 - Val Brickates Kennedy
Avanir, Opexa gain ahead of presentations 3:16 p.m. April 6, 2010 - Val Brickates Kennedy
Avanir shares jump 10% in pre-market action 9:27 a.m. April 6, 2010 - Val Brickates Kennedy
Drug stocks pressured by J&J report; Avanir jumps 1:49 p.m. Oct. 13, 2009 - Val Brickates Kennedy
Avanir, Acorda move on MS drug updates 3:51 p.m. Oct. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 6:10 p.m. Aug. 11, 2009 - MarketWatch
Avanir soars and Javelin sinks on drug studies 1:15 p.m. Aug. 11, 2009 - Val Brickates Kennedy

Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% - Tale of the Tape 8:52 a.m. Sept. 19, 2014 - Zacks.com
Merck KGaA Teams Up with Sutro for ADCs Targeting Cancer - Analyst Blog 7:00 p.m. Sept. 18, 2014 - Zacks.com
Insider Trading Alert - RSG, HAL And AVNR Traded By Insiders 10:30 a.m. Sept. 18, 2014 - TheStreet.com
Biotech Stock Roundup: Avanir Soars on Phase II Data, Orexigen's Contrave Approved - Analyst Blog 3:00 p.m. Sept. 17, 2014 - Zacks.com
All Pop And No Sizzle Or Is Avanir Going Higher From Here? 9:30 a.m. Sept. 17, 2014 - Seeking Alpha
Merck KGaA-Lupin Ink Deal, Focus on Emerging Markets - Analyst Blog 4:14 p.m. Sept. 16, 2014 - Zacks.com
Avanir Pharmaceuticals Shoots Up on Positive AVP-923 Data - Analyst Blog 3:50 p.m. Sept. 16, 2014 - Zacks.com
AVANIR Pharmaceuticals (AVNR) Showing Signs Of Perilous Reversal Today 9:45 a.m. Sept. 16, 2014 - TheStreet.com
Is Avanir Pharma Fully Valued After Monday’s Rally? 9:13 a.m. Sept. 16, 2014 - 247WallSt.com
Benzinga's Top #PreMarket Losers 7:11 a.m. Sept. 16, 2014 - benzinga.com
Why Avanir Pharmaceuticals (AVNR) Stock Soared to a One-Year High Today 4:06 p.m. Sept. 15, 2014 - TheStreet.com
Merck KGaA Stops All Tecemotide Studies for Lung Cancer - Analyst Blog 3:42 p.m. Sept. 15, 2014 - Zacks.com
Terex Falls After Lowered Earnings Forecast; Avanir Pharmaceuticals Shares Surge 2:40 p.m. Sept. 15, 2014 - benzinga.com
Concert Pharma rides Avanir's coattails 1:30 p.m. Sept. 15, 2014 - Seeking Alpha
NASDAQ Tumbles 1.1%; Alere Shares Surge Following Proposed $46/Share Offer 12:24 p.m. Sept. 15, 2014 - benzinga.com
Midday Gainers From September 15 - RadioShack Corporation, Rewalk Robotics Ltd And More 11:32 a.m. Sept. 15, 2014 - benzinga.com
Alzheimer’s Study Results Take Avanir Back Up to Multiyear Highs 10:26 a.m. Sept. 15, 2014 - 247WallSt.com
Markets Fall; Cognizant To Acquire TriZetto For $2.7 Billion 10:26 a.m. Sept. 15, 2014 - benzinga.com
Morning Market Movers 8:42 a.m. Sept. 15, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – AVNR PTCT AZN HALO 8:30 a.m. Sept. 15, 2014 - InvestorPlace.com

Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK 9:05 a.m. Sept. 18, 2014 - PR Newswire - PRF
Critical Alerts For Yahoo!, El Pollo Loco, Avanir Pharmaceuticals, General Electric and Ballard Power Systems Released By InvestorsObserver 9:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Reveal Insider Trading for Yahoo, Apple, Facebook, Avanir Pharmaceuticals, Tesla Motors, and Twitter 8:55 a.m. Sept. 16, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease 8:30 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 9:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference 9:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 9:00 a.m. Aug. 26, 2014 - PR Newswire - PRF
Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma 9:10 a.m. Aug. 6, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update 4:01 p.m. Aug. 5, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Date of Fiscal 2014 Third Quarter Financial Results and Conference Call 8:31 a.m. July 28, 2014 - GlobeNewswire
Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 9:15 a.m. July 21, 2014 - PR Newswire - PRF
Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. to Serve on EPIRUS Board of Directors 11:50 a.m. July 15, 2014 - BusinessWire - BZX
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals 5:10 a.m. July 14, 2014 - PR Newswire - PRF
Stocks Coverage on the Pharma Industry -- Research on Zoetis, Mylan, AVANIR Pharma, and Actavis 6:50 a.m. July 1, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Two Data Presentations Related to Pseudobulbar Affect (PBA) at the Alzheimer's Association International Conference (AAIC) 7:22 p.m. June 30, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 6:40 a.m. June 27, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine 4:00 a.m. June 10, 2014 - PR Newswire - PRF
Health Care Sector Equities Scrutiny -- Research on AVANIR Pharma, Zoetis, Actavis, and Mallinckrodt 7:50 a.m. June 3, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Completion of Patient Enrollment in Study of AVP-923 for the Treatment of Agitation in Patients with Alzheimer's Disease 9:00 a.m. May 27, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Second Quarter Financial and Business Results 4:01 p.m. May 6, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Suunto Unleashes High-Tech Race 3S Watch with AI Coach

The Latest in Performance Gear: Suunto's Race 3S Nobody wants their gear to be a limitation, especially out in the wild where every step counts. Enter Suunto's Race 3S—a watch that looks to change the game for those passionate about trail running. This gadget's packed with features meant for athletes who are serious about their tech, yet light enough to make you forget...

Dairy Blends Market Eyes USD 15.38B by 2035 Growth

The dairy blends market, set to barrel towards USD 15.38 billion by 2035 according to Credence Research, isn't just a numbers game. It's a tug-of-war between different fats, regions, and regulations. For those betting on future market movements, this shouldn't be a passing glance. Rising from USD 9.97 billion in 2025, these figures suggest consistent waves rather than...

Winter Prep: Home Safety Vital for Older Adults

Cold Weather is All About Precaution It ain't the first day at the fair when you realize winter's sneaking up, and with it, the looming concern of older family members hunkering down indoors. Executive Home Care's calling out, saying it straight: if you've got seniors in your midst, now's the time to batten down the hatches. The winter months can turn into a slippery...

Selling Montana Cabins: Tips from Shawna Norry

Understanding the Challenges of Selling Montana Cabins When folks think about selling real estate, the logistics of marketing quaint Montana cabins or lifestyle properties can be different than your typical city apartment. In the wide-open spaces of places like Libby, Montana, seller needs aren't just about showing a property—it's about telling a story. Shawna Norry, an...

Trive Cashes Out on EarthLink, New Era with Family Offices

EarthLink's Changing Hands: What's the Real Deal? I tell you, the tech industry's like a game of hot potato, and right now, EarthLink's the spud getting tossed around. Trive Capital, the private equity force from Dallas, just wrapped up handing EarthLink over to a family office squad. That's WaveDivision Capital, The Pritzker Organization, and Stephens Capital Partners...

M&T Bank Declares Quarterly Preferred Dividends

No Surprises Here—M&T Pays Out Big On Preferreds If there's one thing the market just loves to see amid all this noise and chatter, it's cash coming back to shareholders. M&T Bank Corporation, a seasoned player in the financial sector, is keeping its shareholders happy with some neat quarterly preferred stock dividends. Now, if you've been poking around the NYSE:MTB...

Lincoln's Legal Tangle: Stock Plunge Sparks Lawsuit

Lincoln Educational's Troubles Unravel You think you've seen it all, then boom—Lincoln Educational Services hit the skids with their stock diving close to 25% back in August 2026. This ain't your usual small hiccup; we’re talking a lawsuit filed and investors eyeing action as miserly as a broker when the market tumbles. News like this? It shakes the rafters of any...

Cecilia Vicuña's Bold Exhibition at MOCA Tackles Water Crisis

Art and ecological awareness dance together on a tightrope at the Museum of Contemporary Art (MOCA) in Los Angeles. Cecilia Vicuña’s new exhibition, The Dream of Water: Quipu of Encounters Maricunga, arrives with a punch, not merely as art but as a call to arms for water conservation and environmental justice. The show kicks off on November 15, 2026, and remains open...

Digital Maps Revolutionize Navigation at UK Hospitals

Technology Making Strides in Patient Navigation You ever get lost in one of those labyrinthine hospitals? It's a nightmare, isn't it? Well, it seems St George's and Epsom hospitals have taken a step forward with a solution—MazeMap. The idea is simple: digital wayfinding. Patients and visitors have a digital map at their fingertips, helping them hop through the maze of...

WuXi Biologics Clinches Top ESG Honors in Award Circuit

Pounding the ESG Pavement Every now and then, a story pops up that makes you wonder if the finance folks are finally waking up to what's been slap-you-in-the-face obvious: sustainability ain't just a fancy word for do-gooders anymore. It's the real ticket to the future, and WuXi Biologics (2269.HK) just snagged the top-honor Jade Award at The Asset Corporate...